Table of Contents Table of Contents
Previous Page  86 / 490 Next Page
Information
Show Menu
Previous Page 86 / 490 Next Page
Page Background

84

SCIENTIFIC PROGRAMME

| PROGRAMME AND EXHIBITION GUIDE

SATURDAY 30 APRIL 2016

INTERDISCIPLINARY RADIOBIOLOGY

CLINICAL BRACHYTHERAPY PHYSICS

RTT

YOUNG

16:40 > Growth and oedema related shifts of brain metastasis treated with

stereotactic radiosurgery

K. De Vries (The Netherlands), M. Beerendonk, L. Dewit, W. Boogerd,

D. Brandsma, A. Van Mourik, G. Borst

OC-0160

16:50 > Renal and diaphragmatic interfractional motion in children and adults:

is there a difference?

I.W.E.M. Van Dijk (The Netherlands), S.C. Huijskens, M.A.J. De Jong,

J. Visser, R. Dávila Fajardo, C.R.N. Rasch, T. Alderliesten, A. Bel

OC-0161

17:00 > Liquid fiducial markers’ performance in non small cell lung cancer

during radiotherapy

J. Scherman Rydhög (Denmark), S. Riisgaard Mortensen, K. Richter Larsen,

P. Clementsen, R. Irming Jølck, M. Josipovic, M. Aznar, G. Persson,

T.L. Andresen, L. Specht, P. Munck af Rosenschöld

OC-0162

17:10 > Robustness of proton RT with different beam angles towards inter-

fractional motion in the pelvis

A. Andersen (Denmark), O. Casares-Magaz, J. Petersen, J. Toftegaard,

L. Bentzen, S. Thörnqvist, L. Muren

OC-0163

17:20 > Integrate range shifting in immobilisation for proton therapy:

3D printed materials characterisation

S. Michiels (Department of Oncology), N. Lammens, A. D’Hollander,

K. Poels, W. Crijns, G. Defraene, S. Nuyts, K. Haustermans, T. Depuydt

OC-0164

Proffered Papers

RTT 2: IMPROVINGQUALITY FOR BREAST CANCER TREATMENTS

16:30 - 17:30 | ROOM 3

Chair: L. Van den Berghe (Belgium)

Chair: P. Simons (The Netherlands)

16:30 > Deep inspiration breath hold - can it be detrimental to the heart?

B. Done (Australia), A. Michalski, A. Windsor

OC-0165

16:40 > The influence of tumour location in the breast on boost modality

selection.

E. Reilly (UK), C. Baker, M. Flynn, H.M.O. Mayles, A.J. Reilly

OC-0166

16:50 > Advanced left-side breast cancer: does VMAT allow doses of organs

at risk to be reduced?

P.C. Yu (Taiwan), H.H. Nien, C.J. Wu, Y.L. Tsai

OC-0167